Microbot Medical Inc. (MBOT)
USD 0.97
(-3.69%)
USD 0.97
(-3.69%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 40 Thousand USD | -77.65% |
| 2022 | 179 Thousand USD | -55.47% |
| 2021 | 402 Thousand USD | -35.78% |
| 2020 | 626 Thousand USD | -17.63% |
| 2019 | 760 Thousand USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | -100.0% |
| 2016 | 76 Thousand USD | -99.15% |
| 2015 | 8.91 Million USD | -13.71% |
| 2014 | 10.33 Million USD | 11.78% |
| 2013 | 9.24 Million USD | 6616.5% |
| 2012 | 137.64 Thousand USD | -58.45% |
| 2011 | 331.25 Thousand USD | -38.71% |
| 2010 | 540.47 Thousand USD | -31.11% |
| 2009 | 784.57 Thousand USD | -9.46% |
| 2008 | 866.52 Thousand USD | -16.23% |
| 2007 | 1.03 Million USD | -9.69% |
| 2006 | 1.14 Million USD | 0.0% |
| 2005 | - USD | -100.0% |
| 2004 | 1.64 Million USD | -10.98% |
| 2003 | 1.84 Million USD | -11.36% |
| 2002 | 2.08 Million USD | -9.9% |
| 2001 | 2.31 Million USD | -11.1% |
| 2000 | 2.6 Million USD | -11.31% |
| 1999 | 2.93 Million USD | -22.71% |
| 1998 | 3.8 Million USD | -7.32% |
| 1997 | 4.1 Million USD | -50.0% |
| 1996 | 8.2 Million USD | 51.85% |
| 1995 | 5.4 Million USD | -3.57% |
| 1994 | 5.6 Million USD | 64.71% |
| 1993 | 3.4 Million USD | -12.82% |
| 1992 | 3.9 Million USD | 457.14% |
| 1991 | 700 Thousand USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 17 Thousand USD | 0.0% |
| 2024 Q2 | 38 Thousand USD | 0.0% |
| 2023 Q4 | 40 Thousand USD | 2.56% |
| 2023 Q2 | 92 Thousand USD | -27.56% |
| 2023 Q1 | 127 Thousand USD | -29.05% |
| 2023 FY | 40 Thousand USD | -77.65% |
| 2023 Q3 | 39 Thousand USD | -57.61% |
| 2022 Q4 | 179 Thousand USD | -20.8% |
| 2022 Q1 | 386 Thousand USD | -3.98% |
| 2022 FY | 179 Thousand USD | -55.47% |
| 2022 Q3 | 226 Thousand USD | -18.71% |
| 2022 Q2 | 278 Thousand USD | -27.98% |
| 2021 Q2 | 543 Thousand USD | -3.89% |
| 2021 Q1 | 565 Thousand USD | -9.74% |
| 2021 FY | 402 Thousand USD | -35.78% |
| 2021 Q4 | 402 Thousand USD | -7.8% |
| 2021 Q3 | 436 Thousand USD | -19.71% |
| 2020 FY | 626 Thousand USD | -17.63% |
| 2020 Q2 | 667 Thousand USD | -3.75% |
| 2020 Q3 | 629 Thousand USD | -5.7% |
| 2020 Q1 | 693 Thousand USD | -8.82% |
| 2020 Q4 | 626 Thousand USD | -0.48% |
| 2019 Q2 | 188 Thousand USD | -24.8% |
| 2019 Q3 | 131 Thousand USD | -30.32% |
| 2019 Q1 | 250 Thousand USD | 0.0% |
| 2019 FY | 760 Thousand USD | 0.0% |
| 2019 Q4 | 760 Thousand USD | 480.15% |
| 2018 Q3 | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q2 | - USD | -100.0% |
| 2017 FY | - USD | -100.0% |
| 2017 Q1 | 245 Thousand USD | 222.37% |
| 2016 FY | 76 Thousand USD | -99.15% |
| 2016 Q1 | 8.92 Million USD | 0.14% |
| 2016 Q2 | 1206.28 USD | -99.99% |
| 2016 Q4 | 76 Thousand USD | 7682.4% |
| 2016 Q3 | 976.56 USD | -19.04% |
| 2015 FY | 8.91 Million USD | -13.71% |
| 2015 Q1 | 9.28 Million USD | -10.2% |
| 2015 Q2 | 8.93 Million USD | -3.7% |
| 2015 Q3 | 8.93 Million USD | -0.05% |
| 2015 Q4 | 8.91 Million USD | -0.17% |
| 2014 Q2 | 11.12 Million USD | -8.21% |
| 2014 Q4 | 10.33 Million USD | -14.23% |
| 2014 Q1 | 12.12 Million USD | 31.1% |
| 2014 FY | 10.33 Million USD | 11.78% |
| 2014 Q3 | 12.04 Million USD | 8.3% |
| 2013 Q3 | 9.9 Million USD | 41.38% |
| 2013 Q4 | 9.24 Million USD | -6.62% |
| 2013 FY | 9.24 Million USD | 6616.5% |
| 2013 Q1 | 82.09 Thousand USD | -40.36% |
| 2013 Q2 | 7 Million USD | 8430.05% |
| 2012 Q2 | 231.25 Thousand USD | -17.78% |
| 2012 Q3 | 193.16 Thousand USD | -16.47% |
| 2012 Q4 | 137.64 Thousand USD | -28.74% |
| 2012 FY | 137.64 Thousand USD | -58.45% |
| 2012 Q1 | 281.25 Thousand USD | -15.09% |
| 2011 Q3 | 371.41 Thousand USD | -13.62% |
| 2011 Q1 | 476.25 Thousand USD | -11.88% |
| 2011 Q4 | 331.25 Thousand USD | -10.81% |
| 2011 FY | 331.25 Thousand USD | -38.71% |
| 2011 Q2 | 430 Thousand USD | -9.71% |
| 2010 Q1 | 725.74 Thousand USD | -7.5% |
| 2010 FY | 540.47 Thousand USD | -31.11% |
| 2010 Q4 | 540.47 Thousand USD | -10.57% |
| 2010 Q3 | 604.33 Thousand USD | -9.33% |
| 2010 Q2 | 666.49 Thousand USD | -8.16% |
| 2009 Q1 | 921.44 Thousand USD | 6.34% |
| 2009 FY | 784.57 Thousand USD | -9.46% |
| 2009 Q4 | 784.57 Thousand USD | -6.93% |
| 2009 Q3 | 843 Thousand USD | -6.31% |
| 2009 Q2 | 899.79 Thousand USD | -2.35% |
| 2008 Q1 | 964.86 Thousand USD | -6.73% |
| 2008 FY | 866.52 Thousand USD | -16.23% |
| 2008 Q4 | 866.52 Thousand USD | 5.61% |
| 2008 Q3 | 820.49 Thousand USD | -8.35% |
| 2008 Q2 | 895.22 Thousand USD | -7.22% |
| 2007 Q1 | 1.11 Million USD | -2.84% |
| 2007 Q2 | 1.11 Million USD | 0.14% |
| 2007 FY | 1.03 Million USD | -9.69% |
| 2007 Q4 | 1.03 Million USD | -3.79% |
| 2007 Q3 | 1.07 Million USD | -3.53% |
| 2006 Q1 | 1.28 Million USD | 0.0% |
| 2006 Q3 | 1.17 Million USD | -3.55% |
| 2006 FY | 1.14 Million USD | 0.0% |
| 2006 Q2 | 1.22 Million USD | -5.05% |
| 2006 Q4 | 1.14 Million USD | -2.76% |
| 2005 Q1 | 1.57 Million USD | -4.62% |
| 2005 FY | - USD | -100.0% |
| 2005 Q2 | 1.49 Million USD | -4.88% |
| 2005 Q4 | - USD | -100.0% |
| 2005 Q3 | 1.41 Million USD | -5.19% |
| 2004 Q1 | 1.78 Million USD | -3.24% |
| 2004 FY | 1.64 Million USD | -10.98% |
| 2004 Q2 | 1.72 Million USD | -3.35% |
| 2004 Q3 | 1.66 Million USD | -3.57% |
| 2004 Q4 | 1.64 Million USD | -1.29% |
| 2003 Q4 | 1.84 Million USD | -3.14% |
| 2003 Q1 | 2.02 Million USD | -2.82% |
| 2003 Q3 | 1.9 Million USD | -3.03% |
| 2003 Q2 | 1.96 Million USD | -2.9% |
| 2003 FY | 1.84 Million USD | -11.36% |
| 2002 Q1 | 2.25 Million USD | -2.43% |
| 2002 FY | 2.08 Million USD | -9.9% |
| 2002 Q4 | 2.08 Million USD | -2.74% |
| 2002 Q3 | 2.14 Million USD | -2.63% |
| 2002 Q2 | 2.2 Million USD | -2.49% |
| 2001 Q3 | 2.35 Million USD | -3.44% |
| 2001 Q4 | 2.31 Million USD | -1.61% |
| 2001 FY | 2.31 Million USD | -11.1% |
| 2001 Q1 | 2.52 Million USD | -3.21% |
| 2001 Q2 | 2.43 Million USD | -3.32% |
| 2000 Q1 | 2.85 Million USD | -2.79% |
| 2000 FY | 2.6 Million USD | -11.31% |
| 2000 Q2 | 2.77 Million USD | -2.8% |
| 2000 Q3 | 2.69 Million USD | -2.97% |
| 2000 Q4 | 2.6 Million USD | -3.25% |
| 1999 Q4 | 2.93 Million USD | -5.26% |
| 1999 Q1 | 3.2 Million USD | -15.79% |
| 1999 FY | 2.93 Million USD | -22.71% |
| 1999 Q2 | 3.1 Million USD | -3.13% |
| 1999 Q3 | 3.1 Million USD | 0.0% |
| 1998 Q4 | 3.8 Million USD | -7.32% |
| 1998 Q2 | 4.7 Million USD | 20.51% |
| 1998 Q1 | 3.9 Million USD | -4.88% |
| 1998 FY | 3.8 Million USD | -7.32% |
| 1998 Q3 | 4.1 Million USD | -12.77% |
| 1997 FY | 4.1 Million USD | -50.0% |
| 1997 Q2 | 7.6 Million USD | -2.56% |
| 1997 Q3 | 7.5 Million USD | -1.32% |
| 1997 Q4 | 4.1 Million USD | -45.33% |
| 1997 Q1 | 7.8 Million USD | -4.88% |
| 1996 FY | 8.2 Million USD | 51.85% |
| 1996 Q4 | 8.2 Million USD | 12.33% |
| 1996 Q3 | 7.3 Million USD | 25.86% |
| 1996 Q1 | 5.2 Million USD | -3.7% |
| 1996 Q2 | 5.8 Million USD | 11.54% |
| 1995 Q2 | 5.3 Million USD | -1.85% |
| 1995 FY | 5.4 Million USD | -3.57% |
| 1995 Q4 | 5.4 Million USD | 3.85% |
| 1995 Q3 | 5.2 Million USD | -1.89% |
| 1995 Q1 | 5.4 Million USD | -3.57% |
| 1994 Q1 | 3.2 Million USD | -5.88% |
| 1994 Q4 | 5.6 Million USD | 51.35% |
| 1994 Q3 | 3.7 Million USD | 5.71% |
| 1994 Q2 | 3.5 Million USD | 9.38% |
| 1994 FY | 5.6 Million USD | 64.71% |
| 1993 Q2 | 3.7 Million USD | -2.63% |
| 1993 Q4 | 3.4 Million USD | 0.0% |
| 1993 FY | 3.4 Million USD | -12.82% |
| 1993 Q1 | 3.8 Million USD | -2.56% |
| 1992 Q4 | 3.9 Million USD | 0.0% |
| 1992 FY | 3.9 Million USD | 457.14% |
| 1991 Q4 | 700 Thousand USD | 0.0% |
| 1991 FY | 700 Thousand USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 75.25 Million USD | 99.947% |
| AngioDynamics, Inc. | 3.93 Million USD | 98.985% |
| AtriCure, Inc. | 60.59 Million USD | 99.934% |
| Avinger, Inc. | - USD | -Infinity% |
| Azenta, Inc. | 60.43 Million USD | 99.934% |
| BioLife Solutions, Inc. | 18.31 Million USD | 99.782% |
| The Cooper Companies, Inc. | 2.52 Billion USD | 99.998% |
| Daxor Corporation | 755.65 Thousand USD | 94.707% |
| Ekso Bionics Holdings, Inc. | 4.83 Million USD | 99.172% |
| Femasys Inc. | 4.25 Million USD | 99.061% |
| GlucoTrack, Inc. | 196 Thousand USD | 79.592% |
| Harvard Bioscience, Inc. | 30.7 Million USD | 99.87% |
| Hologic, Inc. | 2.49 Billion USD | 99.998% |
| ICU Medical, Inc. | 1.57 Billion USD | 99.997% |
| Intuitive Surgical, Inc. | -82.1 Million USD | 100.049% |
| KORU Medical Systems, Inc. | 3.65 Million USD | 98.905% |
| LeMaitre Vascular, Inc. | 16.62 Million USD | 99.759% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Masimo Corporation | 871.7 Million USD | 99.995% |
| Meihua International Medical Technologies Co., Ltd. | 4592.00 USD | -771.08% |
| Merit Medical Systems, Inc. | 823.01 Million USD | 99.995% |
| Nephros, Inc. | 1.39 Million USD | 97.122% |
| NovoCure Limited | 596.24 Million USD | 99.993% |
| NEXGEL, Inc. | 513 Thousand USD | 92.203% |
| NEXGEL, Inc. | 513 Thousand USD | 92.203% |
| Singular Genomics Systems, Inc. | 67.52 Million USD | 99.941% |
| OraSure Technologies, Inc. | 11.38 Million USD | 99.649% |
| Pro-Dex, Inc. | 7.53 Million USD | 99.469% |
| Pulse Biosciences, Inc. | 8.08 Million USD | 99.505% |
| Predictive Oncology Inc. | 2.18 Million USD | 98.173% |
| Precision Optics Corporation, Inc. | 1.93 Million USD | 97.936% |
| QuidelOrtho Corporation | 2.27 Billion USD | 99.998% |
| Repligen Corporation | 510.14 Million USD | 99.992% |
| Sanara MedTech Inc. | 9.11 Million USD | 99.561% |
| STAAR Surgical Company | 31.46 Million USD | 99.873% |
| Sharps Technology, Inc. | - USD | -Infinity% |
| Utah Medical Products, Inc. | 295 Thousand USD | 86.441% |
| DENTSPLY SIRONA Inc. | 1.79 Billion USD | 99.998% |
| Jin Medical International Ltd. | - USD | -Infinity% |